[Efficacy of autologous preserved marrow on patients undergoing myelodepressive therapeutic treatment].
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects*; D016026:Bone Marrow Transplantation; D003520:Cyclophosphamide / Q000009:adverse effects*; D003864:Depression, Chemical; D005260:Female; D005615:Freezing; D006410:Hematopoiesis / Q000187:drug effects* / Q000528:radiation effects; D006801:Humans; D006834:Hydrazines / Q000009:adverse effects*; D007275:Injections, Intravenous; D008297:Male; D008722:Methods; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D014021:Tissue Preservation; D014182:Transplantation, Autologous
D000970:Antineoplastic Agents; D006834:Hydrazines; D003520:Cyclophosphamide
Efficacia del midollo autologo conservato su pazienti sottoposti a trattamento terapeutico mielodepressivo.